Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 25% ± 10% | |
oligodendrocyte | 9 studies | 27% ± 9% | |
oligodendrocyte precursor cell | 8 studies | 27% ± 11% | |
GABAergic neuron | 7 studies | 35% ± 19% | |
astrocyte | 7 studies | 30% ± 11% | |
glutamatergic neuron | 6 studies | 43% ± 24% | |
microglial cell | 6 studies | 26% ± 8% | |
epithelial cell | 6 studies | 23% ± 6% | |
neuron | 5 studies | 31% ± 15% | |
adipocyte | 5 studies | 21% ± 4% | |
fibroblast | 5 studies | 19% ± 2% | |
macrophage | 5 studies | 28% ± 3% | |
cardiac muscle cell | 4 studies | 18% ± 1% | |
interneuron | 4 studies | 41% ± 22% | |
myeloid cell | 3 studies | 20% ± 2% | |
ciliated cell | 3 studies | 20% ± 0% | |
monocyte | 3 studies | 18% ± 0% | |
lymphocyte | 3 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2214.47 | 1445 / 1445 | 100% | 26.96 | 183 / 183 |
lung | 100% | 2244.66 | 578 / 578 | 100% | 16.08 | 1154 / 1155 |
prostate | 100% | 2522.15 | 245 / 245 | 100% | 19.80 | 500 / 502 |
brain | 100% | 1620.49 | 2637 / 2642 | 100% | 15.50 | 702 / 705 |
breast | 100% | 2648.93 | 459 / 459 | 99% | 21.27 | 1107 / 1118 |
ovary | 100% | 3076.14 | 180 / 180 | 99% | 10.76 | 425 / 430 |
thymus | 100% | 2241.15 | 653 / 653 | 98% | 14.97 | 595 / 605 |
intestine | 100% | 2386.01 | 966 / 966 | 98% | 13.44 | 518 / 527 |
stomach | 100% | 1656.84 | 359 / 359 | 98% | 16.73 | 281 / 286 |
pancreas | 100% | 1211.94 | 327 / 328 | 98% | 11.39 | 174 / 178 |
uterus | 100% | 3042.65 | 170 / 170 | 97% | 12.45 | 446 / 459 |
bladder | 100% | 2579.71 | 21 / 21 | 97% | 11.35 | 489 / 504 |
adrenal gland | 100% | 2137.10 | 258 / 258 | 96% | 10.09 | 221 / 230 |
kidney | 100% | 1471.01 | 89 / 89 | 96% | 13.10 | 864 / 901 |
skin | 100% | 2403.19 | 1809 / 1809 | 92% | 10.34 | 433 / 472 |
liver | 100% | 1028.66 | 226 / 226 | 71% | 4.94 | 290 / 406 |
adipose | 100% | 2557.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2457.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2177.44 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1331.17 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1203.40 | 853 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 14.59 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 8.27 | 25 / 29 |
peripheral blood | 71% | 988.71 | 660 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 4.70 | 55 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046620 | Biological process | regulation of organ growth |
GO_0017015 | Biological process | regulation of transforming growth factor beta receptor signaling pathway |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0035329 | Biological process | hippo signaling |
GO_0030833 | Biological process | regulation of actin filament polymerization |
GO_2000058 | Biological process | regulation of ubiquitin-dependent protein catabolic process |
GO_0001827 | Biological process | inner cell mass cell fate commitment |
GO_0033146 | Biological process | regulation of intracellular estrogen receptor signaling pathway |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0051301 | Biological process | cell division |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0051220 | Biological process | cytoplasmic sequestering of protein |
GO_0060644 | Biological process | mammary gland epithelial cell differentiation |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0043254 | Biological process | regulation of protein-containing complex assembly |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0000819 | Biological process | sister chromatid segregation |
GO_1900181 | Biological process | negative regulation of protein localization to nucleus |
GO_0006468 | Biological process | protein phosphorylation |
GO_0045736 | Biological process | negative regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0001828 | Biological process | inner cell mass cellular morphogenesis |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0030496 | Cellular component | midbody |
GO_0000922 | Cellular component | spindle pole |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LATS1 |
Protein name | Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts) LATS1 protein (Large tumor suppressor kinase 1) Large tumor suppressor kinase 1 |
Synonyms | WARTS |
Description | FUNCTION: Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 . . |
Accessions | ENST00000458696.2 ENST00000543571.6 [O95835-1] O95835 ENST00000392273.7 [O95835-2] ENST00000253339.9 [O95835-1] Q6PJG3 ENST00000441107.5 H0YG09 ENST00000542720.1 |